Kieran MW - Search Results

1

Inhibition of tumor angiogenesis by oral etoposide.

Panigrahy D, Kaipainen A, Butterfield CE, Chaponis DM, Laforme AM, Folkman J, Kieran MW. Panigrahy D, et al. Among authors: kieran mw. Exp Ther Med. 2010 Sep;1(5):739-746. doi: 10.3892/etm.2010.127. Epub 2010 Jul 21. Exp Ther Med. 2010. PMID: 22993597 Free PMC article.

2

Antiangiogenic therapy and p53.

Browder T, Folkman J, Hahnfeldt P, Heymach J, Hlatky L, Kieran M, Rogers MS. Browder T, et al. Science. 2002 Jul 26;297(5581):471; discussion 471. Science. 2002. PMID: 12143876 No abstract available.

3

Angiogenesis inhibitors and hypoxia.

Kieran MW, Folkman J, Heymach J. Kieran MW, et al. Nat Med. 2003 Sep;9(9):1104; author reply 1104-5. doi: 10.1038/nm0903-1104a. Nat Med. 2003. PMID: 12949515 No abstract available.

4

Therapeutic potential of thiazolidinediones as anticancer agents.

Panigrahy D, Shen LQ, Kieran MW, Kaipainen A. Panigrahy D, et al. Among authors: kieran mw. Expert Opin Investig Drugs. 2003 Dec;12(12):1925-37. doi: 10.1517/13543784.12.12.1925. Expert Opin Investig Drugs. 2003. PMID: 14640937 Review.

5

The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study.

Applebaum H, Kieran MW, Cripe TP, Coffin CM, Collins MH, Kaipainen A, Laforme A, Shamberger RC. Applebaum H, et al. Among authors: kieran mw. J Pediatr Surg. 2005 Jun;40(6):999-1003; discussion 1003. doi: 10.1016/j.jpedsurg.2005.03.016. J Pediatr Surg. 2005. PMID: 15991185

6

PPARgamma as a therapeutic target for tumor angiogenesis and metastasis.

Panigrahy D, Huang S, Kieran MW, Kaipainen A. Panigrahy D, et al. Among authors: kieran mw. Cancer Biol Ther. 2005 Jul;4(7):687-93. doi: 10.4161/cbt.4.7.2014. Epub 2005 Jul 13. Cancer Biol Ther. 2005. PMID: 16082179 Review.

7

A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.

Kieran MW, Turner CD, Rubin JB, Chi SN, Zimmerman MA, Chordas C, Klement G, Laforme A, Gordon A, Thomas A, Neuberg D, Browder T, Folkman J. Kieran MW, et al. J Pediatr Hematol Oncol. 2005 Nov;27(11):573-81. doi: 10.1097/01.mph.0000183863.10792.d4. J Pediatr Hematol Oncol. 2005. PMID: 16282886 Clinical Trial.

8

ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.

Rich JN, Sathornsumetee S, Keir ST, Kieran MW, Laforme A, Kaipainen A, McLendon RE, Graner MW, Rasheed BK, Wang L, Reardon DA, Ryan AJ, Wheeler C, Dimery I, Bigner DD, Friedman HS. Rich JN, et al. Among authors: kieran mw. Clin Cancer Res. 2005 Nov 15;11(22):8145-57. doi: 10.1158/1078-0432.CCR-05-0319. Clin Cancer Res. 2005. PMID: 16299247

9

AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.

Sathornsumetee S, Hjelmeland AB, Keir ST, McLendon RE, Batt D, Ramsey T, Yusuff N, Rasheed BK, Kieran MW, Laforme A, Bigner DD, Friedman HS, Rich JN. Sathornsumetee S, et al. Among authors: kieran mw. Cancer Res. 2006 Sep 1;66(17):8722-30. doi: 10.1158/0008-5472.CAN-06-0284. Cancer Res. 2006. PMID: 16951188

10

PPARalpha deficiency in inflammatory cells suppresses tumor growth.

Kaipainen A, Kieran MW, Huang S, Butterfield C, Bielenberg D, Mostoslavsky G, Mulligan R, Folkman J, Panigrahy D. Kaipainen A, et al. Among authors: kieran mw. PLoS One. 2007 Feb 28;2(2):e260. doi: 10.1371/journal.pone.0000260. PLoS One. 2007. PMID: 17327920 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page